<DOC>
	<DOCNO>NCT02747641</DOCNO>
	<brief_summary>The purpose study ass use Alma CO2 Pixel FemiLift™ treatment VulvoVaginal Atrophy ( VVA ) postmenopausal female subject . The primary endpoint ass change vaginal dryness mean Visual Analogic Scale ( 10 cm VAS ) and/or Bachmann Index VVA . The clinical improvement assess patient fill Vulvovaginal Atrophy .</brief_summary>
	<brief_title>Prospective , Open-Label , Single-Center , Non-Comparative Study Assess Use Pixel CO2 Laser System ( FemiLift ) Treatment Vulvovaginal Atrophy ( VVA ) Postmenopausal Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Genital Diseases , Female</mesh_term>
	<criteria>Healthy , nonsmoking Woman , age 35 70 yr , menopausal Provided write Informed Consent Exhibiting VVA and/or SUI symptom ( mild moderate SUI , accord severity index develop Sandvik . ) Prolapse stag &lt; II , accord pelvic organ prolapse quantification ( ICSPOPQ ) system Normal PAP smear ( 1 year prior baseline ) Vaginal canal , introitus vestibule free injury bleed Have procedure anatomical area 6 month prior treatment Understand accept obligation logistically able present schedule followup visit Severe prolapse ( POP &gt; = grade 3 ) Use photosensitive drug Acute recurrent urinary tract infection ( UTI ) , genital infection ( e.g . herpes candida ) . Any serious disease , chronic condition , could interfere study compliance Acute actively present within last 2 month HPV/HSV Undiagnosed vaginal bleeding Urge overflow incontinence Patients antidepressant , αadrenergic anticholinergic medication Patients immune system disease . Patients allergic reaction laser . Obese woman ( BMI &gt; 30 ) Patient unable follow posttreatment instruction History keloid formation Received anticipate receive antiplatelets , anticoagulant , thrombolytic , vitamin E anti inflammatories within 2 week pre treatment A history thrombophlebitis A history acute infection A history heart failure Previously undergone reconstructive pelvic surgery Have use vaginal cream , moisturizers , lubricant homeopathic preparation least 3 month Any medical condition investigator opinion would interfere patient participation study</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>